Erratum: The role of hypoxia inducible factor-1 alpha in bypassing oncogene-induced senescence (PLoS ONE (2014) 9:7 (e101064) DOI: 10.1371/journal.pone.0101064);The role of hypoxia inducible factor-1 alpha in bypassing oncogene-induced senescence

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Eren, Mehtap Kilic ^a   Tabor, Vedrana ^b  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATR PROTEIN; BETA GALACTOSIDASE; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HETEROCHROMATIN PROTEIN 1 GAMMA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ONCOPROTEIN; PROTEIN GAMMA H2AX; PROTEIN H3K9ME3; PROTEIN P53; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; HIF1A PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIPLOIDY; DNA DAMAGE; DOWN REGULATION; ENZYME PHOSPHORYLATION; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; ONCOGENE; ONCOGENE H RAS; ONCOGENE RAS; SENESCENCE; ANOXIA; CELL AGING; CELL CULTURE; CYTOLOGY; METABOLISM; PHYSIOLOGY;

ANOXIA; CELL AGING; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DIPLOIDY; DOWN-REGULATION; FIBROBLASTS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ONCOGENES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84903729827     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110981     Document Type: Erratum

References (45)

1. Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621.
2. Ben-Porath I, Weinberg RA (2005) The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 37: 961-976. (Pubitemid 40311739)
3. Land H, Parada LF, Weinberg RA (1983) Cellular oncogenes and multistep carcinogenesis. Science 222: 771-778. (Pubitemid 14227542)
4. Franza BR Jr, Maruyama K, Garrels JI, Ruley HE (1986) In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes. Cell 44: 409-418. (Pubitemid 16043332)
5. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602. (Pubitemid 27152402)
6. Maldonado JL, Timmerman L, Fridlyand J, Bastian BC (2004) Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway. Am J Pathol 164: 1783-1787. (Pubitemid 38529780)
7. Collado M, Serrano M (2005) The senescent side of tumor suppression. Cell Cycle 4: 1722-1724. (Pubitemid 41827312)
8. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, et al. (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444: 633-637. (Pubitemid 44864442)
9. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, et al. (2006) Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444: 638-642. (Pubitemid 44864443)
10. Rodier F, Campisi J (2009) When DNA damage goes invisible. Cell Cycle 8: 3632-3633.
11. Shamma A, Takegami Y, Miki T, Kitajima S, Noda M, et al. (2009) Rb Regulates DNA damage response and cellular senescence through E2F-dependent suppression of N-ras isoprenylation. Cancer Cell 15: 255-269.
12. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, et al. (2005) Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434: 907-913. (Pubitemid 40559004)
13. Kilic M, Schmitt CA (2008) Tumor senescence in cancer treatment. Part 6. Chapter III. "Exploiting drug induced senescence in transgenic mouse models" BEYOND APOPTOSIS: CELLULAR OUTCOMES OF CANCER THERAPY, in: Dale Bredesen, Martin Brown and Igor Roninson ed. New York: Informa Health Care USA. pp. 273.
14. Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, et al. (2002) A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109: 335-346. (Pubitemid 34606876)
15. Welford SM, Bedogni B, Gradin K, Poellinger L, Broome Powell M, et al. (2006) HIF1alpha delays premature senescence through the activation of MIF. Genes Dev 20: 3366-3371. (Pubitemid 44969155)
16. Bell EL, Klimova TA, Eisenbart J, Schumacker PT, Chandel NS (2007) Mitochondrial reactive oxygen species trigger hypoxia-inducible factor-dependent extension of the replicative life span during hypoxia. Mol Cell Biol 27: 5737-5745. (Pubitemid 47257830)
17. Sullivan R, Pare GC, Frederiksen LJ, Semenza GL, Graham CH (2008) Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity. Mol Cancer Ther 7: 1961-1973.
18. Welford SM, Giaccia AJ (2011) Hypoxia and senescence: the impact of oxygenation on tumor suppression. Mol Cancer Res 9: 538-544.
19. von Zglinicki T, Saretzki G, Docke W, Lotze C (1995) Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res 220: 186-193.
20. Lee AC, Fenster BE, Ito H, Takeda K, Bae NS, et al. (1999) Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem 274: 7936-7940.
21. Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S, et al. (2003) Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol 5: 741-747. (Pubitemid 36986782)
22. Semenza GL (2001) HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 13: 167-171.
23. Kilic M, Kasperczyk H, Fulda S, Debatin KM (2007) Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance. Oncogene 26: 2027-2038. (Pubitemid 46514744)
24. Kinsella TM, Nolan GP (1996) Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther 7: 1405-1413. (Pubitemid 26293560)
25. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92: 9363-9367.
26. Narita M, Nunez S, Heard E, Lin AW, Hearn SA, et al. (2003) Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703-716. (Pubitemid 36724935)
27. Ben-Porath I, Weinberg RA (2004) When cells get stressed: an integrative view of cellular senescence. J Clin Invest 113: 8-13. (Pubitemid 38541623)
28. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, et al. (2005) Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436: 660-665. (Pubitemid 41117262)
29. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720-724. (Pubitemid 41117276)
30. Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C, et al. (2006) Identification of a tumour suppressor network opposing nuclear Akt function. Nature 441: 523-527. (Pubitemid 44050155)
31. Packer L, Fuehr K (1977) Low oxygen concentration extends the lifespan of cultured human diploid cells. Nature 267: 423-425. (Pubitemid 8105518)
32. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, et al. (2000) Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 14: 34-44. (Pubitemid 30051577)
33. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, et al. (1998) Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 392: 405-408.
34. de Stanchina E, Querido E, Narita M, Davuluri RV, Pandolfi PP, et al. (2004) PML is a direct p53 target that modulates p53 effector functions. Mol Cell 13: 523-535. (Pubitemid 38299380)
35. Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C, et al. (2000) PML is induced by oncogenic ras and promotes premature senescence. Genes Dev 14: 2015-2027. (Pubitemid 30637352)
36. Benanti JA, Galloway DA (2004) The normal response to RAS: senescence or transformation? Cell Cycle 3: 715-717. (Pubitemid 40187896)
37. Benanti JA, Galloway DA (2004) Normal human fibroblasts are resistant to RAS-induced senescence. Mol Cell Biol 24: 2842-2852. (Pubitemid 38381274)
38. Box AH, Demetrick DJ (2004) Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines. Carcinogenesis 25: 2325-2335. (Pubitemid 39625172)
39. Mallette FA, Goumard S, Gaumont-Leclerc MF, Moiseeva O, Ferbeyre G (2004) Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence. Oncogene 23: 91-99. (Pubitemid 38142243)
40. Brookes S, Rowe J, Ruas M, Llanos S, Clark PA, et al. (2002) INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence. EMBO J 21: 2936-2945. (Pubitemid 34670378)
41. Bos JL (1989) ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689.
42. Cox AD, Der CJ (2003) The dark side of Ras: regulation of apoptosis. Oncogene 22: 8999-9006. (Pubitemid 38121700)
43. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, et al. (1997) Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385: 544-548. (Pubitemid 27074674)
44. Hueber AO, Evan GI (1998) Traps to catch unwary oncogenes. Trends Genet 14: 364-367.
45. Hammond EM, Giaccia AJ (2004) The role of ATM and ATR in the cellular response to hypoxia and re-oxygenation. DNA Repair (Amst) 3: 1117-1122. (Pubitemid 38997955)